Longevity / Aging Therapeutic

Iron Reduction (ferritin lowering)

sex-stratified Grade and summary pending review Evidence Grade Strength of published clinical evidence — not a safety rating or a recommendation. How to read this

Dimension Scores

Human Outcome

•

Biomarker Relevance

•

Signal Source Quality

•

Organ Specificity

•

Interaction Certainty

•

Translational Maturity

•

Per-dimension evidence strength is part of the full analysis Unlock full analysis

No indication-level signals recorded yet. The grade above has not been decomposed, so it should be read as a whole-compound assessment rather than a claim about any one indication.

Evidence Summary

This entry grades the intervention, lowering body iron through phlebotomy or blood donation, rather than ferritin as a test. Three lines of evidence disagree: observational data is heavily confounded, genetic evidence suggests higher iron shortens lifespan, and the one randomised trial missed its primary endpoint while showing a secondary cancer signal. Risk direction reverses by sex, with high ferritin associated with harm in men and low ferritin with harm in women.

Evidence Signals (0)

🔒

Create a free account to see signal-level evidence grades.

Create a free account

Products Containing Iron Reduction (ferritin lowering)

No commercial products are currently listed for this molecule.

This evidence profile reflects publicly available research as of October 22, 2026. Evidence grades may change as new research is published. ClinEvident grades the quality of published evidence — it does not evaluate the efficacy of any specific commercial product.